You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cladribine

Showing 101 - 125 of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)

Recruiting
  • Hairy Cell Leukemia
  • Low dose vemurafenib plus rituximab
  • La Jolla, California
    Scripps MD Anderson Cancer Center
May 19, 2022

Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

Active, not recruiting
Has Results
  • Hairy Cell Leukemia
  • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022

Langerhans Cell Histiocytosis Trial in United States (drug, procedure, biological)

Recruiting
  • Langerhans Cell Histiocytosis
  • Birmingham, Alabama
  • +35 more
Feb 17, 2022

Lymphoma Trial in China (Chidamide, Cladribine, gemcitabine)

Unknown status
  • Lymphoma
  • Beijing, Beijing, China
  • +17 more
Jul 16, 2018

Offspring Neurocognitive Development and Behaviour

Recruiting
  • Multiple Sclerosis
  • Exposure to methylprednisolone during pregnancy
  • Bochum, Germany
  • +1 more
Aug 8, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Aggressive Therapy or Traditional Therapy
  • Birmingham, Alabama
  • +51 more
Jan 23, 2023

Diffuse Cutaneous Systemic Sclerosis Trial (Brentuximab vedotin)

Not yet recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Brentuximab vedotin
  • (no location specified)
Apr 11, 2022

Waldenstrom's Macroglobulinemia Trial in Athens, Rotterdam, Salamanca (Bortezomib, Rituximab, Dexamethasone)

Completed
  • Waldenstrom's Macroglobulinemia
  • Bortezomib, Rituximab, Dexamethasone
  • Athens, Attica, Greece
  • +3 more
Apr 27, 2021

Acute Myeloid Leukemia Trial in Baltimore (Calaspargase pegol-mknl)

Recruiting
  • Acute Myeloid Leukemia
  • Calaspargase pegol-mknl
  • Baltimore, Maryland
    Greenebaum Cancer Center, University of Maryland Medical Systems
Dec 14, 2021

ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Blood withdrawal
  • Pozzilli, Isernia, Italy
    IRCCS Neuromed
Oct 7, 2019

Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses Trial in Nashville (Harmonized supportive care, Cyclosporine 5 mg/kg bid

Not yet recruiting
  • Stevens-Johnson Syndrome
  • Toxic Epidermal Necrolyses
  • Harmonized supportive care
  • +2 more
  • Nashville, Tennessee
    Vanderblt University Medical Center
Dec 29, 2022

Lymphoma Trial in Portland (biological, drug, genetic, other)

Terminated
Has Results
  • Lymphoma
  • rituximab
  • +7 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Nov 15, 2019

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Indolent Adult Non-Hodgkin Lymphoma

Completed
Has Results
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +3 more
  • Cladribine
  • +3 more
  • Portland, Oregon
  • +1 more
Nov 9, 2017

Langerhans Cell Histiocytosis Trial in Moscow (Vemurafenib, Cytarabine, 2-chlorodeoxyadenosine)

Unknown status
  • Langerhans Cell Histiocytosis
  • Moscow, Russian Federation
    Dmitry Rogachev National Research Center of Pediatric Hematology
Apr 6, 2020

Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma Trial in Milan (Rituximab, Cladribine)

Terminated
  • Chronic Lymphocytic Leukaemia
  • Small Lymphocytic Lymphoma
  • Milan, Italy
    European Institute of Oncology
Jan 30, 2018

Acute Myeloid Leukemia (AML) Trial in Hershey (Pevonedistat, transplant, Azacitidine)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Hershey, Pennsylvania
    Penn State Hershey Medical Center: Penn State Cancer Institute
Nov 22, 2020

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
Has Results
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

Mantle Cell Lymphoma Trial in Hershey (Rituximab, bortezomib, Cladribine)

Unknown status
  • Mantle Cell Lymphoma
  • Hershey, Pennsylvania
  • +1 more
Aug 4, 2017

Acute Myeloid Leukaemia, Myelodysplastic Syndrome Trial in Denmark, United Kingdom (Arm A Mylotarg plus DA Versus CPX-351, Arm B

Unknown status
  • Acute Myeloid Leukaemia
  • Myelodysplastic Syndrome
  • Arm A Mylotarg plus DA Versus CPX-351
  • +5 more
  • Aalborg, Denmark
  • +86 more
Jan 22, 2020

Use of Tamoxifen in Systemic Mastocytosis

Completed
  • Systemic Mastocytosis
    • Rochester, Minnesota
      Mayo Clinic
    Apr 9, 2020

    Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Tumors Trial run by the NCI (75 approved agents, COXEN)

    Completed
    Has Results
    • Urothelial Carcinoma
    • +2 more
    • 75 approved agents
    • COXEN
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 14, 2020

    Chronic Lymphocytic Leukemia, Leukemia Trial (dasatinib and lenalidomide)

    Withdrawn
    • Chronic Lymphocytic Leukemia
    • Leukemia
    • dasatinib and lenalidomide
    • (no location specified)
    Apr 9, 2019

    Relapsing Remitting Multiple Sclerosis Trial in Milan (Fingolimod, Dimethyl Fumarate)

    Terminated
    • Relapsing Remitting Multiple Sclerosis
    • Milan, Italy
      Fondazione IRCCS Istituto Neurologico C. Besta, Neuroimmunology
    Oct 29, 2019

    Lymphoma Trial in United States (rituximab, cladribine, temsirolimus)

    Completed
    • Lymphoma
    • rituximab
    • +4 more
    • Scottsdale, Arizona
    • +143 more
    Jan 8, 2018

    Lymphoma Trial (rituximab, cladribine)

    Completed
    • Lymphoma
    • rituximab
    • cladribine
    • (no location specified)
    Dec 5, 2016